Evaluation of the Role of Nesfatin-1 and Myonectin as A Diagnostic Marker for Polycystic Ovary Syndrome and Also for Treatment Response with Metformin - Egyptian Knowledge Bank - troweb

305089

Evaluation of the Role of Nesfatin-1 and Myonectin as A Diagnostic Marker for Polycystic Ovary Syndrome and Also for Treatment Response with Metformin

Article

Last updated: 24 Dec 2024

Overview Similar Items

Article

Serum Adropin and Vaspin Levels in Obese Rats with Polycystic Ovary Syndrome and After Metformin Treatment

Article

The Role of Serum Adiponectin Levels in Women with Polycystic Ovarian Syndrome

Article

Comparative study between the effects of metformin monotherapy in obese and non-obese patients with polycystic ovary syndrome

Article

SERUM NESFATIN-1 LEVELS IN EXPERIMENTALLY-INDUCED POLYCYSTIC OVARY IN LEAN AND OBESE ALBINO RATS

Article

Copeptin and Obestatin Levels in Polycystic Ovary women and their Relation to Obesity, insulin metabolism and Cardiovascular diseases

Article

Clinicopathologic Study of Endometrial and Hormonal Changes after Metformin Therapy in Patients with Polycystic Ovary Syndrome

Article

Evaluation of Circulating Serum Meteorin-like Protein Levels in Obesity and Type 2 Diabetes Mellitus

Article

Serum Resistin and Plasma Visfatin: Relation to Insulin Resistance and Hyperandrogenism in Women with Polycystic Ovary Syndrome

Article

METFORMIN TREATMENT IN INSULIN RESISTANT POLYCYSTIC OVARIES PATIENTS

Article

Measurement Visfatin Level and Its Genetic Polymorphisms (rs61330082) in Women with Polycystic Ovary Syndrome With and Without Insulin Resistance